Search results
Results from the WOW.Com Content Network
A U.S. biotech company has halted sales of its DNA testing products in the Chinese ethnic region of Tibet, as lawmakers mull export controls to keep Beijing from using American products to conduct ...
(Reuters) -The U.S. Senate's homeland security committee voted on Wednesday to approve a bill that could restrict business with Chinese biotech companies like BGI and WuXi AppTec on national ...
NEW YORK (Reuters) -Martin Makary, President Donald Trump's nominee to run the U.S. FDA, will be tasked with maintaining the agency's gold standard status among international drug regulators while ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Valeant Pharmaceuticals: Allergan, Inc: 45 60 Valeant Pharmaceuticals and activist investor Bill Ackman offered to buy Botox maker Allergan, proposing a cash-and-stock deal worth about $152.89. [31] 20 2014 Monsanto Company Inc. Syngenta AG: 40 53 Monsanto weighed $40 billion unsolicited bid for Swiss rival, Syngenta aiming to avoid US ...
Bipartisan bills introduced in Congress Thursday would effectively ban a Chinese genomics firm from doing business in America. Intel officials have warned China is grabbing U.S. genetic info.
Currently slated to open in 2023, the Chengdu facility (MFG12) will be a 1.3 × 10 ^ 6 sq ft (120 × 10 ^ 3 m 2), with an integrated manufacturing center for innovative biologics and dedicated to R&D and commercial-scale bulk active pharmaceutical ingredient (API) production with an initial bioreactor capacity of 48,000 liters (11,000 imp gal ...